NC
Neurocompute
AI-powered research intelligence
 Partner With Us →
Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 40,405 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

Explore Platform → See latest papers
40,405 Papers indexed
1,440 Papers AI scored
40,405 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.
LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
LATEST PEDIATRIC CANCER PAPERS

Database feed

Last ingest 2026-11-13 10:15 AM
1 Interventions to reduce paediatric cancer treatment abandonment in low-income and middle-income countries: a systematic review and meta-analysis. The Lancet. Global health — Nov 13, 2026 2 Paediatric cancer treatment abandonment: multifaceted solutions required. The Lancet. Global health — Nov 13, 2026 3 Enteral Clonidine for the Management of Rigors in Pediatric Oncology. Journal of palliative medicine — Nov 13, 2026 4 Real-world implementation of optic pathway glioma surveillance in children with neurofibromatosis type 1: a 20-year cohort study. The British journal of ophthalmology — Nov 13, 2026 5 Pediatric-type Follicular Lymphoma Shows Unique Immunogenetic Features With Lack of Acquired N-glycosylation Sites. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc — Nov 13, 2026 6 Epigenetic Divergence Distinguishes Molecularly and Histologically Distinct Subtypes of Small Cell Carcinoma of the Ovary Hypercalcemic Type. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc — Nov 13, 2026 7 Radiation in Spine Care: A Comprehensive Review of Radiation Sources, Emerging Technology, Cancer Risk, and Radiation Stewardship. The spine journal : official journal of the North American Spine Society — Nov 13, 2026 8 Polycyclic Aromatic Hydrocarbons in Urban Motor-Park Soils of Asaba, Nigeria: Environmental Contamination, Source Characterization, and Human Health Risk. Environmental pollution (Barking, Essex : 1987) — Nov 13, 2026
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

40405 results
D
Temporal alignment of longitudinal weight change in childhood cancer survival analysis.
PMID 42790257 Published: 2026-09-19 Ingested: 2026-09-27 09:15 AM Clinical nutrition (Edinburgh, Scotland)
AI -
Standard 30.12
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 30.1/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 18.1; sample size: 20.0; recency: 100.0; abstract quality: 0.0.

D
Hemorrhagic Cardiac Tamponade Due to MRSA Sepsis in a Child with Relapsed Acute Lymphoblastic Leukemia: Authors' Reply.
PMID 42397494 Published: 2026-07-03 Ingested: 2026-08-02 12:07 AM Indian journal of pediatrics
AI -
Standard 30.12
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 30.1/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 18.1; sample size: 20.0; recency: 100.0; abstract quality: 0.0.

D
Hemorrhagic Cardiac Tamponade Due to MRSA Sepsis in a Child with Relapsed Acute Lymphoblastic Leukemia: Correspondence.
PMID 42313262 Published: 2026-06-18 Ingested: 2026-08-02 12:07 AM Indian journal of pediatrics
AI -
Standard 30.12
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 30.1/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 18.1; sample size: 20.0; recency: 100.0; abstract quality: 0.0.

D
Communicating Hydrocephalus as a Manifestation of Central Nervous System Relapse of Acute Lymphoblastic Leukemia in a 10-year-old Child.
PMID 42160389 Published: 2026-05-20 Ingested: 2026-08-02 12:06 AM Journal of pediatric hematology/oncology
AI -
Standard 30.12
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 30.1/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 18.1; sample size: 20.0; recency: 100.0; abstract quality: 0.0.

D
High-dose methotrexate toxicokinetic variability persists despite standardized 24-hour infusion in childhood ALL.
PMID 42053824 Published: 2026-04-29 Ingested: 2026-08-02 12:06 AM Cancer chemotherapy and pharmacology
AI -
Standard 30.12
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 30.1/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 18.1; sample size: 20.0; recency: 100.0; abstract quality: 0.0.

D
CNS Embryonal Tumour With PLAG Family Gene Alteration: Failure of Response to RET Inhibition.
PMID 41986227 Published: 2026-04-01 Ingested: 2026-08-02 12:06 AM Neuropathology and applied neurobiology
AI -
Standard 30.12
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 30.1/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 18.1; sample size: 20.0; recency: 100.0; abstract quality: 0.0.

D
Monitoring progress in global childhood cancer survival.
PMID 41905379 Published: 2026-03-26 Ingested: 2026-08-02 12:06 AM Lancet (London, England)
AI -
Standard 30.12
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 30.1/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 18.1; sample size: 20.0; recency: 100.0; abstract quality: 0.0.

D
Editorial: Immune response in EBV infection: from persistence to viral-associated tumours.
PMID 41869334 Published: 2026-03-06 Ingested: 2026-08-02 12:06 AM Frontiers in immunology
AI -
Standard 30.12
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 30.1/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 18.1; sample size: 20.0; recency: 100.0; abstract quality: 0.0.

D
Improved survival, disparate outcomes contemporaneously define the modern worldwide burden of childhood cancers.
PMID 41734902 Published: 2026-01-01 Ingested: 2026-08-02 12:06 AM CA: a cancer journal for clinicians
AI -
Standard 30.12
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 30.1/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 18.1; sample size: 20.0; recency: 100.0; abstract quality: 0.0.

D
Pursuing Global Health Equity in Childhood Cancer Survival.
PMID 40911900 Published: 2025-09-05 Ingested: 2026-08-02 12:05 AM Academic medicine : journal of the Association of American Medical Colleges
AI -
Standard 30.12
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 30.1/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 18.1; sample size: 20.0; recency: 100.0; abstract quality: 0.0.

D
Biomarker-Negative and MIBG-Negative Neuroblastoma Presenting as an Indeterminate Retroperitoneal Mass in a Young Child.
PMID 42634483 Published: 2026-01-01 Ingested: 2026-08-26 09:15 AM Pediatrics international : official journal of the Japan Pediatric Society
AI -
Standard 29.85
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 29.9/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 16.8; sample size: 20.0; recency: 100.0; abstract quality: 0.0.

Previous
Page 3345 of 3368
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.
Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic